We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ubiquigent Launches First Novel Compound Library

News   Sep 14, 2016

 
Ubiquigent Launches First Novel Compound Library
 
 
 

RELATED ARTICLES

Targeting a Protease To Treat Inflammatory Bowel Disease

News

The protease MT1-MMP could be a possible future target for drugs to treat inflammatory bowel disease (IBD) according to a new study.

READ MORE

Ribosome-based Treatments: A Sought After Therapy Option for Orphan Diseases?

News

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

READ MORE

Compound Combo Shrinks Pancreatic Tumors in Mice Providing Rationale for Clinical Study

News

Scientists have identified a combination of two anti-cancer compounds that were able to shrink pancreatic tumors in mice – supporting the immediate evaluation of the drugs in a clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE